Intl. webinar on ‘Pharmaceutical Chemistry and Intellectual Property Rights held
News

Intl. webinar on ‘Pharmaceutical Chemistry and Intellectual Property Rights held

January 12, 2021

Mysore/Mysuru: Rev. Msgr.Leslie Moras, Episcopal Vicar for Educational and Health Ministries, Diocese of Mysuru, said that over the years, with the advancement in Pharmaceutical research, there is a need to bridge the gap between Pharmaceutical Industry and wellness of human beings. Intellectual Property Right (IPR) laws have a special role to play in this and somewhere someone has to take responsibility, he said.  

 Rev. Msgr. Leslie Moras was delivering the inaugural address of the International Webinar on ‘Pharmaceutical Chemistry and Intellectual Property Rights’ hosted by Department of Chemistry, St. Philomena’s College (Autonomous), Mysuru in association with Visvesvaraya Trade Promotional Centre (VTPC) and Department of Industries and Commerce, Government of Karnataka from Jan.7 to 9.

 After briefing about the importance and relevance of the webinar in the contemporary context, he said that people look at Pharmaceutical Industries not only to cure diseases of individual people but large masses of people where lives are at stake. Today, we are caught up in a situation where the whole mankind is looking for solutions. Solutions for the health of man, solutions for wellness and solutions for how best we can find to make health a right of everyone. A lot of people are involved in developing and innovating Research and Development and a lot of people from Law Department and also from the Intellectual Property Rights will create the ethical aspects to make the Pharmaceutical companies to own their responsibility, he said. 

Dr. T. Ruth Shantha Kumari, Principal, welcomed. Rev. Fr. Dr. Bernard Prakash Barnis, Rector-Manager, St.Philomena’s Educational Institutions, presided. 

READ ALSO  Kolkata doctor murder case: St. Philomena’s College takes out silent protest march

Prof. K.M. Mahadevan, former Registrar (Evaluation), University of Mysore, delivered keynote address.  Prabhavati Rao, Facilitator, IP initiative, VTPC, gave introductory address on IPR.

Dr. K. Shridhara Bhat, Technical coordinator, ArkGen Pharma, Bengaluru, spoke on “Interesting aspects of Fluorine Chemistry.” Bindu Sharma, Founder and CEO of Origiin IP solutions, Bengaluru, on “Relevance of IPR for Pharma Industry.”

On day-2, Prof. N.S. Srinivasulu, National University of Juridicial Sciences, Kolkata, spoke on “Intellectual Property Rights and Patents”; Dr. S. Basappa, UoM, threw light on  “Recent Advances in the Target based Drug Development in Cancer Biology.”

On day-3, Dr. Nikhil R. Gandasi, Uppsala University, Sweden, spoke on “Sub-Cellular view on Diabetes and mode of action of GLP1 analogues and sulfonylurea Drugs”; Dr. Devaraja Acharya from West Hertfordshire Hospitals NHS Trust, UK, shared his views on “Covid-19 Pandemic and beyond, experience of Frontline UK Doctor.”

 Prof. Balakrishna Kalluraya, Department of Studies in Chemistry from Mangalore University, delivered the valedictory address. More than 400 participants from India and abroad attended the webinar and gave their feedback. 

ABOUT

Mysuru’s favorite and largest circulated English evening daily has kept the citizens of Mysuru informed and entertained since 1978. Over the past 45 years, Star of Mysore has been the newspaper that Mysureans reach for every evening to know about the happenings in Mysuru city. The newspaper has feature rich articles and dedicated pages targeted at readers across the demographic spectrum of Mysuru city. With a readership of over 2,50,000 Star of Mysore has been the best connection between it’s readers and their leaders; between advertisers and customers; between Mysuru and Mysureans.

CONTACT

Academy News Papers Private Limited, Publishers, Star of Mysore & Mysuru Mithra, 15-C, Industrial ‘A’ Layout, Bannimantap, Mysuru-570015. Phone no. – 0821 249 6520

To advertise on Star of Mysore, email us at

Online Edition: [email protected]
Print Editon: [email protected]
For News/Press Release: [email protected]